Showing results (101-110 of 138) with videos related to

Sort By:
Pageof 14
Frontiers in Pharmacology|February 23, 2023
Palbociclib impairs the proliferative capacity of activated T cells while retaining their cytotoxic efficacyClaudia Arndt, Antje Tunger, Rebekka Wehner, et al.
Haematologica|February 25, 2010
CD271 antigen defines a subset of multipotent stromal cells with immunosuppressive and lymphohematopoietic engraftment-promoting propertiesSelim Kuçi, Zyrafete Kuçi, Hermann Kreyenberg, et al.
Stem Cell Reviews and Reports|August 26, 2025
Knock Out of miRNA-30a-5p and Reconstitution of the Actin Network Dynamics Partly Restores the Impaired Terminal Erythroid Differentiation during Blood PharmingJessica Thiel, Duran Sürün, Desiree C Brändle, et al.
Circulation. Heart Failure|December 10, 2009
Clinical outcome 2 years after intracoronary administration of bone marrow-derived progenitor cells in acute myocardial infarctionBirgit Assmus, Andreas Rolf, Sandra Erbs, et al.
Oncoimmunology|July 9, 2015
Accumulation of tolerogenic human 6-sulfo LacNAc dendritic cells in renal cell carcinoma is associated with poor prognosisMarieta Toma, Rebekka Wehner, Anja Kloß, et al.
Frontiers in Immunology|September 4, 2023
ErbB2 (HER2)-CAR-NK-92 cells for enhanced immunotherapy of metastatic fusion-driven alveolar rhabdomyosarcomaCatrin Heim, Laura M Moser, Herman Kreyenberg, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|February 11, 2010
IL-2-driven regulation of NK cell receptors with regard to the distribution of CD16+ and CD16- subpopulations and in vivo influence after haploidentical NK cell infusionSabine Huenecke, Stefanie Yvonne Zimmermann, Stephan Kloess, et al.
Transfusion Medicine and Hemotherapy : Offizielles Organ Der Deutschen Gesellschaft Fur Transfusionsmedizin Und Immunhamatologie|June 28, 2021
Donors for SARS-CoV-2 Convalescent Plasma for a Controlled Clinical Trial: Donor Characteristics, Content and Time Course of SARS-CoV-2 Neutralizing AntibodiesSixten Körper, Bernd Jahrsdörfer, Victor M Corman, et al.
Transfusion|December 8, 2010
Adoptive transfer and selective reconstitution of streptamer-selected cytomegalovirus-specific CD8+ T cells leads to virus clearance in patients after allogeneic peripheral blood stem cell transplantationAnita Schmitt, Torsten Tonn, Dirk H Busch, et al.
Blood|May 24, 2014
Lowest numbers of primary CD8(+) T cells can reconstitute protective immunity upon adoptive immunotherapyChristian Stemberger, Patricia Graef, Marcus Odendahl, et al.
Pageof 14